J. Goldman & Co’s ARTHROCARE CORP ARTC Stock Holding History

J. Goldman & Co’s Portfolio ARTC Stock Details ARTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-14,599	Closed	-$587K	–	357
2013 Q4	$587K	Buy	+14,599	New	+$541K	0.07%	184

Other funds holding ARTC

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

J. Goldman & Co's ARTC Position: Q1 2014 in Review

J. Goldman & Co sold out of ARTHROCARE CORP (ARTC) in Q1 2014, closing a stake of 14,599 shares — an estimated $587K sold.

J. Goldman & Co first reported a position in ARTC in Q4 2013 and held it in 1 quarter. The position peaked at $587K in Q4 2013. 117 funds tracked by Wall St. Rank hold ARTC as of Q1 2014.

J. Goldman & Co reported no remaining ARTHROCARE CORP position as of Q1 2014 after selling out during the quarter.
J. Goldman & Co sold 14,599 ARTHROCARE CORP shares in Q1 2014, an estimated $587K.
J. Goldman & Co first reported a position in ARTHROCARE CORP in Q4 2013 and held it in 1 quarter.
J. Goldman & Co's ARTHROCARE CORP position peaked at $587K in Q4 2013.
117 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q1 2014.

Based on J. Goldman & Co's 13F filing for Q1 2014, filed 15 May 2014.